Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aceragen Inc ACGN

Aceragen, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the clinical development, and commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs. The Company’s pipeline includes ACG-701 to treat cystic fibrosis (CF) pulmonary exacerbations (PEx) and melioidosis, and... see more

Recent & Breaking News (NDAQ:ACGN)

Leading Health Care Stock for Small-Cap Stars is Chromadex Corp (CDXC) for August 28

Equities.com August 28, 2014

Leading Health Care Stock for Small-Cap Stars is Arrowhead Research Corp (ARWR) for August 26

Equities.com August 26, 2014

Leading Health Care Stock for Small-Cap Stars is Inovio Pharmaceuticals Inc. (INO) for August 21

Equities.com August 21, 2014

Leading Small-Cap Stars Health Care Stock for August 19 Morning Session is Horizon Pharma Inc. (HZNP)

Equities.com August 19, 2014

Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update

Business Wire August 12, 2014

Idera Pharmaceuticals and The Myositis Association Join Forces to Advance the Clinical Development of a Novel TLR Antagonist, IMO-8400, for the Treatment of Myositis

Business Wire August 7, 2014

Idera Pharmaceuticals and Collaborators Publish Promising Preclinical Data Targeting microRNA with Gene Silencing Oligonucleotide Technology

Business Wire August 6, 2014

Idera Pharmaceuticals to Host Conference Call and Webcast to Report Second Quarter 2014 Financial Results

Business Wire August 5, 2014

Galectin Therapeutics Inc. (GALT) Leads Small-Cap Stars Health Care Sector for July 18

Equities.com July 18, 2014

Zhone Technologies Inc. (ZHNE) Leads Small-Cap Stars for July 18

Equities.com July 18, 2014

Parkervision Inc. (PRKR) Leads Small-Cap Stars for July 13

Equities.com July 13, 2014

Parkervision Inc. (PRKR) Leads Small-Cap Stars for July 12

Equities.com July 12, 2014

Parkervision Inc. (PRKR) Leads Small-Cap Stars for July 11

Equities.com July 11, 2014

Idera Pharmaceuticals to be Added to the Russell 3000® and Russell 2000® Indexes

Business Wire June 27, 2014

Idera Pharmaceuticals to Participate in a Panel Discussion at the Piper Jaffray GenomeRx Symposium

Business Wire June 17, 2014

Idera Pharmaceuticals to Present at the Nucleic Acid Summit 2014

Business Wire June 13, 2014

DJIA, S&P, Nasdaq Up on European Bank Tweaks

Equities.com June 5, 2014

Small-Cap Star Idera Pharmaceuticals (IDRA) Spikes on Big Day for Stock Market

Equities.com June 5, 2014

Idera Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference

Business Wire May 28, 2014

Idera Pharmaceuticals Reports First Quarter 2014 Financial Results and Provides Update on Key Programs and Business Strategy

Business Wire May 13, 2014